safety of compounded semaglutide Patient Updates Compounded Semaglutide: Safety & Regulation – Compounded GLP-1 Clinical Safety: What

GLP-1 medications are initiated at low doses and gradually increased over several weeks to minimise gastrointestinal side effects

The different effect on the hydration status seen in our groups might have been caused by the different baseline hydration status as fluid retention tends to progress with renal impairment 34

My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides

First, any transient gastrointestinal effects from the injection tend to be most noticeable in the first 24-48 hours, and experiencing them during the workweek means they typically resolve before the weekend